Welcure Drugs Pharmaceuticals Ltd vs Zr2 Bioenergy Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0.18 as of 23 Oct 15:30 . The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2025 .The P/E Ratio of ZR2 Bioenergy Ltd is 1120 as of March 2025 . The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2025 .The Market Cap of ZR2 Bioenergy Ltd is ₹ 99.93 crore as of March 2025 . The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of ZR2 Bioenergy Ltd for the Jun '26 is ₹ 0.42 crore as compare to the Mar '26 revenue of ₹ 0.44 crore. This represent the decline of -4.55% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of ZR2 Bioenergy Ltd for the Jun '26 is ₹ 0.25 crore as compare to the Mar '26 ebitda of ₹ 0.23 crore. This represent the growth of 8.7% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of ZR2 Bioenergy Ltd changed from ₹ -0.26 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of ZR2 Bioenergy Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

About ZR2 Bioenergy Ltd

ZR2 Bioenergy Limited was initially set up as a proprietary concern in 1911, which later on converted into a Private Limited Company as Sardesai Brothers Private Limited in 1939.
In 1961, it was converted into a Public Limited Company under the name and style 'Sardesai Brothers Limited' and was again changed to Gujchem Distillers India Limited' in 1974.
Subsequent to the takeover by the new Management, the Company has changed its name from Gujchem Distillers India Limited to ZR2 Bioenergy Limited with due approval from Registrar of Companies on March 27, 2025. The Company is engaged in the manufacture and sale of Industrial Alcohol, Acetaldehyde, Acetic Acid, and Auxiliaries and Chemicals in India.
It also offers Monochloro Acetic Acid and Carboxy Methyl Cellulose. In 2023, the Company has incorporated wholly-owned subsidiary company called Sera Code Private Limited on July 28, 2022 to carry on the business of Information Technology.

FAQs for the comparison of Welcure Drugs & Pharmaceuticals Ltd and ZR2 Bioenergy Ltd

Which company has a larger market capitalization, Welcure Drugs & Pharmaceuticals Ltd or ZR2 Bioenergy Ltd?

Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr while Market cap of ZR2 Bioenergy Ltd is 186 Cr

What are the key factors driving the stock performance of Welcure Drugs & Pharmaceuticals Ltd and ZR2 Bioenergy Ltd?

The stock performance of Welcure Drugs & Pharmaceuticals Ltd and ZR2 Bioenergy Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Welcure Drugs & Pharmaceuticals Ltd and ZR2 Bioenergy Ltd?

As of October 24, 2026, the Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18. On the other hand, ZR2 Bioenergy Ltd stock price is INR ₹117.0.

How do dividend payouts of Welcure Drugs & Pharmaceuticals Ltd and ZR2 Bioenergy Ltd compare?

To compare the dividend payouts of Welcure Drugs & Pharmaceuticals Ltd and ZR2 Bioenergy Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.